Chihiro Kiyoshima
YOU?
Author Swipe
View article: microRNA in Chorioamnionitis: Emerging Biomarkers for Early Diagnosis
microRNA in Chorioamnionitis: Emerging Biomarkers for Early Diagnosis Open
Chorioamnionitis can lead to preterm birth, which elevates the short- and long-term mortality risks due to neonatal sepsis and brain disease in infants. The clinical diagnosis of chorioamnionitis is imprecise, making accurate maternal and …
View article: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis Open
Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues through…
View article: Trophic And Immunomodulatory Effects of Adipose Tissue-Derived Stem Cells In A Preclinical Murine Model of Endometriosis
Trophic And Immunomodulatory Effects of Adipose Tissue-Derived Stem Cells In A Preclinical Murine Model of Endometriosis Open
Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues through…
View article: MicroRNAs miR-4535 and miR-1915-5p in Amniotic Fluid As Predictive Biomarkers for Chorioamnionitis
MicroRNAs miR-4535 and miR-1915-5p in Amniotic Fluid As Predictive Biomarkers for Chorioamnionitis Open
miR-4535 and miR-1915-5p serve as promising biomarkers for the diagnosis of severe chorioamnionitis.
View article: Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer Open
HB-EGF expression in serum may be a potential therapeutic indicator for novel HB-EGF-targeted therapy in recurrent ovarian cancer.
View article: Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer Open
Ovarian cancer is the most lethal malignancy among gynaecological cancers. Although many anticancer agents have been developed for the treatment of ovarian cancer, it continues to have an extremely poor prognosis. Heparin-binding epidermal…
View article: MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer
MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer Open
Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly target…